REPORTS OF SUSPECTED PURINETHOL SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Purinethol. The information is not vetted and should not be considered as verified clinical evidence.
Possible Purinethol side effects / adverse reactions in 45 year old male
Reported by a physician from Canada on 2011-10-14
Patient: 45 year old male weighing 60.0 kg (132.0 pounds)
Reactions: Small Intestine Carcinoma, Drug Ineffective
Adverse event resulted in: hospitalization
Suspect drug(s):
Remicade
Indication: Crohn's Disease
Start date: 2010-01-01
End date: 2011-06-01
Purinethol
Indication: Crohn's Disease
Start date: 1995-01-01
End date: 2011-06-01
Corticosteroids
Indication: Product Used FOR Unknown Indication
Possible Purinethol side effects / adverse reactions in 45 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-10
Patient: 45 year old male
Reactions: Listeriosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Purinethol
Indication: Colitis Ulcerative
Remicade
Indication: Colitis Ulcerative
Start date: 2011-06-01
Prednisolone
Administration route: Oral
Indication: Colitis Ulcerative
Other drugs received by patient: Fivasa; Imuran
Possible Purinethol side effects / adverse reactions in 42 year old male
Reported by a consumer/non-health professional from Germany on 2012-01-20
Patient: 42 year old male weighing 87.0 kg (191.4 pounds)
Reactions: Hyperbilirubinaemia, Cholestasis
Suspect drug(s):
Vincristine
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-26
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-01
Purinethol
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-07
End date: 2012-01-09
Methotrexate
Dosage: also on 10-jan-2012
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-03
Pegaspargase
Dosage: 1df= 4000u
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-12-26
Dasatinib
Dosage: interrupted:12jan2012.
Indication: Acute Lymphocytic Leukaemia
|